BUSINESS
Tariffs Boost Trump’s Treasury by $50 Billion as Trade Partners Stay Cautious
This has facilitated the US to earn nearly $50 billion in extra customs revenue with relatively minimum foreign resistance.
Trump Signals India-U.S. Trade Agreement Nearing Finalization
"We're very close to a deal with India, where they open it up" to imports from the US, he stated on Wednesday.
US to impose uniform tariff rate on over 150 economies, says Donald Trump
It is a drastic move towards stepping up his administration's trade policy and has already captured international attention.
India’s Pharma Market Soars 11.5% in June, Led by Spike in Acute Therapy Demand
This is a sharp improvement from the 7% growth in June 2024 and a significant one from the 6.9% expansion in May 2025, reflecting a sustained trend of growth in the sector.
Indians Lead Global Buying: Nvidia and Alphabet Top US Stock Picks in Q2
The report showed that Nvidia led trading activity, with 6.4% of total buy volumes and an impressive 8.3% of sell volumes on the Vested platform.
High pharmaceutical tariffs might come at the end of month, says Donald Trump
Trump, as indicated in a report by Yonhap news agency, stated that the tariffs on drugs would be phased in to allow companies to set up manufacturing units inside the United States.
India ‘working along same line’ as US-Indonesia trade deal, Donald Trump
Addressing the media in Washington on Tuesday, Trump emphasized that under the deal with Jakarta, US imports would have a 19 percent tariff, while there would be no tariffs on US exports to Indonesia.
India’s Exports to US Jump 23% in June, Imports See 10% Decline
In the first quarter of FY 2025–26 (April–June), exports to the U.S. increased by 22.18% year-on-year to $25.51 billion.
India’s Exports Rise 6.5% in June; Q1 Sees 5.94% Growth in Goods and Services
Imports, however, registered a modest increase of 0.5%, amounting to $71.50 billion in June 2025 compared to the same month in 2024.
Jane Street Injects $567 Million to Reenter Indian Markets
The action comes after a recent directive by the Securities and Exchange Board of India (SEBI) disallowing the company from engaging in Indian securities markets for suspected market manipulation.
Don't Miss
Advertisement